Canada markets closed

Anatara Lifesciences Ltd (ANR.AX)

ASX - ASX Delayed Price. Currency in AUD
Add to watchlist
0.04600.0000 (0.00%)
As of 04:10PM AEST. Market open.
Currency in AUD

Valuation Measures4

Market Cap (intraday) 7.72M
Enterprise Value 6.43M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)6.31
Price/Book (mrq)6.09
Enterprise Value/Revenue 6.08
Enterprise Value/EBITDA -3.20

Trading Information

Stock Price History

Beta (5Y Monthly) 0.74
52-Week Change 363.33%
S&P500 52-Week Change 321.08%
52 Week High 30.0488
52 Week Low 30.0207
50-Day Moving Average 30.0343
200-Day Moving Average 30.0292

Share Statistics

Avg Vol (3 month) 3167.8k
Avg Vol (10 day) 3246.3k
Shares Outstanding 5167.89M
Implied Shares Outstanding 6167.89M
Float 8105.76M
% Held by Insiders 136.11%
% Held by Institutions 17.58%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 30, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-250.38%

Management Effectiveness

Return on Assets (ttm)-65.37%
Return on Equity (ttm)-117.14%

Income Statement

Revenue (ttm)-123.18k
Revenue Per Share (ttm)-0.00
Quarterly Revenue Growth (yoy)-31.10%
Gross Profit (ttm)N/A
EBITDA -1.76M
Net Income Avi to Common (ttm)-1.75M
Diluted EPS (ttm)-0.0100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.08M
Total Cash Per Share (mrq)0.01
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)8.90
Book Value Per Share (mrq)0.01

Cash Flow Statement

Operating Cash Flow (ttm)-1.54M
Levered Free Cash Flow (ttm)-948.77k